PMS

Manufacturer: Hyland's | Standard Homeopathic Company
Effective date: 2019-12-19
Label type: HUMAN OTC DRUG LABEL
Version: 3
Source: legacy-cache
Hydrated at: 2026-08-01 23:49:19

Label at a glance#

ProductPMS

Active ingredientVIBURNUM OPULUS BARK, CAULOPHYLLUM THALICTROIDES ROOT, ANAMIRTA COCCULUS SEED, GELSEMIUM SEMPERVIRENS ROOT

Label structure7 sections

Dosage and administration

Adults: Dissolve 2-3 tablets under tongue every 4 hours or as needed.

Label contents#

Full prescribing information#

OTC - PURPOSE SECTION

Formerly Hyland's #24, Hyland's PMS is a traditional homeopathic formula for the relief of symptoms of painful menstruation, cramping and irritability associated with the menstrual period. Working without contraindications or side effects, Hyland's PMS stimulates your body's natural healing response to relieve symptoms. Hyland's PMS can be used in conjunction with other medications.

Warnings

WARNINGS SECTION

OTC - DO NOT USE SECTION

Do not use if imprinted cap band is broken or missing.

OTC - ASK DOCTOR SECTION

If symptoms persist for more than seven days or worsen, contact a licensed health care professional.

OTC - PREGNANCY OR BREAST FEEDING SECTION

As with any drug, if you are pregnant or nursing a baby, seek the advice of a licensed health care professional before using this product.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep this and all medications out of the reach of children. In case of accidental overdose, contact a poison control center immediately.

Indications

INDICATIONS & USAGE SECTION

Relief of symptoms of menstrual pain, cramping and irritability associated with the menstrual period.

Directions

DOSAGE & ADMINISTRATION SECTION

Adults: Dissolve 2-3 tablets under tongue every 4 hours or as needed.

FORMULA

OTC - ACTIVE INGREDIENT SECTION

INACTIVE INGREDIENT SECTION

VIBURNUM OPULUS 2X, HPUS; CAULOPHYLLUM THALICTROIDES 3X, HPUS; COCCULUS INDICUS 3X, HPUS; GELSEMIUM SEMPERVIRENS 3X, HPUS IN A BASE OF LACTOSE, USP.

QUESTIONS?

OTC - QUESTIONS SECTION

CALL US: 800/624-9659

PRINCIPAL DISPLAY PANEL - 100 Tablet Bottle Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 54973-2957-02

Hyland's ^®

HOMEOPATHIC

PMS

Natural Relief for Menstrual
Cramps and Irritability.

100
TABLETS

Principal Display Panel - 100 Tablet Bottle Carton

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
ANAMIRTA COCCULUS SEED	ACTIVE INGREDIENT	810258W28U	2
CAULOPHYLLUM THALICTROIDES ROOT	ACTIVE INGREDIENT	JTJ6HH6YEH	2
GELSEMIUM SEMPERVIRENS ROOT	ACTIVE INGREDIENT	639KR60Q1Q	2
VIBURNUM OPULUS BARK	ACTIVE INGREDIENT	T1UG6H6805	2
ANAMIRTA COCCULUS SEED	ACTIVE MOIETY	810258W28U	2
CAULOPHYLLUM THALICTROIDES ROOT	ACTIVE MOIETY	JTJ6HH6YEH	2
GELSEMIUM SEMPERVIRENS ROOT	ACTIVE MOIETY	639KR60Q1Q	2
VIBURNUM OPULUS BARK	ACTIVE MOIETY	T1UG6H6805	2
Lactose	INACTIVE INGREDIENT	J2B2A4N98G	2

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 7 matching rows.

PMS
viburnum opulus bark, caulophyllum thalictroides root, anamirta cocculus seed, and gelsemium sempervirens root
LACTOSE
VIBURNUM OPULUS BARK
CAULOPHYLLUM THALICTROIDES ROOT
ANAMIRTA COCCULUS SEED
GELSEMIUM SEMPERVIRENS ROOT

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
54973-2957	54973-2957-2

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 5 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
LACTOSE	J2B2A4N98G	IACT
VIBURNUM OPULUS BARK	T1UG6H6805	ACTIB
CAULOPHYLLUM THALICTROIDES ROOT	JTJ6HH6YEH	ACTIB
ANAMIRTA COCCULUS SEED	810258W28U	ACTIB
GELSEMIUM SEMPERVIRENS ROOT	639KR60Q1Q	ACTIB

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 36 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
Lactose	LACTOSE	J2B2A4N98G	TABLET / SUBLINGUAL		352 mg	Exact identifier — unii candidate 36 equally ranked IID candidates
Lactose	LACTOSE	J2B2A4N98G	INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS	133 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
Lactose	LACTOSE	J2B2A4N98G	CONCENTRATE / ORAL	NA		Exact identifier — unii candidate 36 equally ranked IID candidates
Lactose	LACTOSE	J2B2A4N98G	POWDER, FOR SOLUTION / ORAL	NA		Exact identifier — unii candidate 36 equally ranked IID candidates
Lactose	LACTOSE	J2B2A4N98G	TABLET, FILM COATED / ORAL	590 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
Lactose	LACTOSE	J2B2A4N98G	TABLET / RECTAL	20 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
Lactose	LACTOSE	J2B2A4N98G	TABLET, EFFERVESCENT / ORAL	96.5 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
Lactose	LACTOSE	J2B2A4N98G	TABLET, FILM COATED, EXTENDED RELEASE / ORAL		620 mg	Exact identifier — unii candidate 36 equally ranked IID candidates
Lactose	LACTOSE	J2B2A4N98G	INJECTION, SOLUTION / INTRAVENOUS	0.45 %w/v		Exact identifier — unii candidate 36 equally ranked IID candidates
Lactose	LACTOSE	J2B2A4N98G	TABLET, COATED / ORAL	332.05 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
Lactose	LACTOSE	J2B2A4N98G	TABLET / ORAL	2500 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
Lactose	LACTOSE	J2B2A4N98G	TABLET, EXTENDED RELEASE / ORAL	400 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
Lactose	LACTOSE	J2B2A4N98G	INJECTION / INTRAMUSCULAR	203.5 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
Lactose	LACTOSE	J2B2A4N98G	GRANULE, FOR SUSPENSION / ORAL	512.5 mg/5ml		Exact identifier — unii candidate 36 equally ranked IID candidates
Lactose	LACTOSE	J2B2A4N98G	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRACAVITARY	193.8 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
Lactose	LACTOSE	J2B2A4N98G	TABLET / BUCCAL	296.7 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
Lactose	LACTOSE	J2B2A4N98G	TABLET, CHEWABLE / ORAL		1412 mg	Exact identifier — unii candidate 36 equally ranked IID candidates
Lactose	LACTOSE	J2B2A4N98G	CAPSULE, COATED PELLETS / ORAL	135.2 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
Lactose	LACTOSE	J2B2A4N98G	TABLET, DELAYED RELEASE / ORAL		160 mg	Exact identifier — unii candidate 36 equally ranked IID candidates
Lactose	LACTOSE	J2B2A4N98G	POWDER / RESPIRATORY (INHALATION)	90 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
Lactose	LACTOSE	J2B2A4N98G	INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR	133 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
Lactose	LACTOSE	J2B2A4N98G	POWDER / VAGINAL	430 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
Lactose	LACTOSE	J2B2A4N98G	SUPPOSITORY / VAGINAL	NA		Exact identifier — unii candidate 36 equally ranked IID candidates
Lactose	LACTOSE	J2B2A4N98G	CREAM / VAGINAL	3 %w/w		Exact identifier — unii candidate 36 equally ranked IID candidates
Lactose	LACTOSE	J2B2A4N98G	OINTMENT / TOPICAL	NA		Exact identifier — unii candidate 36 equally ranked IID candidates
Lactose	LACTOSE	J2B2A4N98G	CAPSULE / ORAL	530 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
Lactose	LACTOSE	J2B2A4N98G	INJECTION / INTRAVENOUS	203.5 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
Lactose	LACTOSE	J2B2A4N98G	CAPSULE, EXTENDED RELEASE / ORAL	120 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
Lactose	LACTOSE	J2B2A4N98G	SOLUTION / ORAL	1682 mg/15ml		Exact identifier — unii candidate 36 equally ranked IID candidates
Lactose	LACTOSE	J2B2A4N98G	CAPSULE, COATED, EXTENDED RELEASE / ORAL	NA		Exact identifier — unii candidate 36 equally ranked IID candidates
Lactose	LACTOSE	J2B2A4N98G	TABLET, SUGAR COATED / ORAL	NA		Exact identifier — unii candidate 36 equally ranked IID candidates
Lactose	LACTOSE	J2B2A4N98G	INJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUS	133 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
Lactose	LACTOSE	J2B2A4N98G	SOLUTION / RECTAL	8 %w/v		Exact identifier — unii candidate 36 equally ranked IID candidates
Lactose	LACTOSE	J2B2A4N98G	CAPSULE, DELAYED RELEASE / ORAL	231.84 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
Lactose	LACTOSE	J2B2A4N98G	FILM, EXTENDED RELEASE / TRANSDERMAL	675 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
Lactose	LACTOSE	J2B2A4N98G	CAPSULE / RESPIRATORY (INHALATION)	44.4 mg		Exact identifier — unii candidate 36 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
9a15d2eb-c7b5-65a8-e053-2a95a90ae4aa			bc2c847b-b895-499f-bce9-adcc1c5786b0	2019-12-19	Warnings	Exact identifier spl id: 9a15d2eb-c7b5-65a8-e053-2a95a90ae4aa spl set id: bc2c847b-b895-499f-bce9-adcc1c5786b0

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.